Название продукции:3-Cyclopropyloxetan-3-ol
IUPAC Name:3-cyclopropyloxetan-3-ol
- CAS:1408291-64-4
- Молекулярная формула:C6H10O2
- Чистота:95%
- Номер в каталоге:CM284568
- Молекулярная масса:114.14
Только для использования в НИОКР..
Информация о продукции
- Номер CAS:1408291-64-4
- Молекулярная формула:C6H10O2
- Точка плавления:-
- Smiles-код:OC1(C2CC2)COC1
- Плотность:
- Номер в каталоге:CM284568
- Молекулярная масса:114.14
- Точка кипения:
- Номер Mdl:MFCD22690228
- Хранение:Keep in inert atmosphere, store at 2-8°C.
Category Infos
- Cyclopropanes
- Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.
- Oxetanes
- Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.